President-elect Donald Trump hosted a dinner at Mar-a-Lago, bringing together Robert F. Kennedy Jr., Pfizer CEO Albert Bourla, Eli Lilly CEO David Ricks, and PhRMA leader Steve Ubl. The meeting reportedly focused on healthcare reform, cancer research, and public-private collaboration.
Kennedy, tapped by Trump to serve as Health and Human Services Secretary, has long criticized pharmaceutical companies, emphasizing the risks they pose when left unchecked by federal oversight. His presence at the table underscores the administration’s interest in balancing innovation with accountability.
Elizabeth McDonald asks Dr. Peter McCullough
"What do you make of this, so Pfizer, Eli Lilly, big pharma execs go to Mar a Lago try to lobby Trump to ease up on them on the make America healthy again push but Trump brought RFK Jr. to the meeting what do you think of all this?"… pic.twitter.com/iy8dBSUU5f
— DrRay (@DrNoMask) December 7, 2024
The pharmaceutical industry has faced scrutiny in recent years, particularly after legislation allowed Medicare to negotiate drug prices. Trump’s healthcare agenda has included promises to reduce costs and ensure that the public’s interests are prioritized over corporate profits.
During the dinner, attendees explored opportunities for collaboration between the government and pharmaceutical companies. Kennedy’s role in these discussions adds a layer of skepticism to the administration’s approach, signaling a willingness to question industry practices while seeking solutions for healthcare challenges.
Big Pharma Eli Lilly Announces $3B Manufacturing Expansion in Kenosha Following Strategic Meeting with Trump and RFK Jr. at Mar-a-Lago | The Gateway Pundit
Kenosha, Wisconsin, is poised for an economic revival, thanks to a groundbreaking $3 billion investment from pharmaceutical… pic.twitter.com/tqwc6e53x6
— Owen Gregorian (@OwenGregorian) December 8, 2024
Dr. Mehmet Oz, Trump’s nominee for leading Medicare and Medicaid Services, also attended the event, contributing to discussions about healthcare delivery and improving access for Americans.
🚨Big Pharma Eli Lilly Announces $3B Manufacturing Expansion in Kenosha Following Strategic Meeting with President Trump and RFK Jr. at Mar-a-Lago
— Tiffany Hudson (@Patriot_NiNi) December 7, 2024
The meeting highlights a critical moment for the Trump administration, as it seeks to reform the healthcare system by leveraging expertise from both the public and private sectors while addressing concerns about corporate influence.
